The search for a peripheral biopsy indicator of a-synuclein pathology for Parkinson disease

Journal of Neuropathology and Experimental Neurology

Volumn 76, Issue 1, 2017, Pages 2-15

  Lee, John M ^a   Derkinderen, Pascal ^b,c,d   Kordower, Jeffrey H ^e   Freeman, Roy ^f   Munoz, David G ^g   Kremer, Thomas ^h   Zago, Wagner ⁱ   Hutten, Samantha J ^j   Adler, Charles H ^k   Serrano, Geidy E ^a   Beach, Thomas G ^l  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b INSERM   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e RUSH MEDICAL COLLEGE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h F HOFFMANN LA ROCHE LTD   (Switzerland)

ⁱ Prothena Biosciences Inc   (United States)

^j THE MICHAEL J FOX FOUNDATION FOR PARKINSON'S RESEARCH   (United States)

^k Mayo Clinic College of Medicine   (United States)

^l SUN HEALTH RESEARCH INSTITUTE   (United States)

more..

Author keywords

Biomarker; Colon; Diagnosis; Lewy body; Prognosis; Skin; Submandibular gland

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER;

AUTOPSY; CELL DIFFERENTIATION; CLINICAL ASSESSMENT; GASTROINTESTINAL BIOPSY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MULTICENTER STUDY (TOPIC); NERVOUS TISSUE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SALIVARY GLAND; SIGMOID; SKIN BIOPSY; SUBMANDIBULAR GLAND; BIOPSY; COLON; METABOLISM; ORGANIZATION; PATHOLOGY; SKIN; TRENDS;

ALPHA-SYNUCLEIN; BIOMARKERS; BIOPSY; COLON; CONGRESSES AS TOPIC; HUMANS; PARKINSON DISEASE; SKIN; SUBMANDIBULAR GLAND;

EID: 85016824623     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1093/jnen/nlw103     Document Type: Review

References (93)

1. Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 1997;38 Suppl 2:2-7
2. Wakabayashi K, Takahashi H, Takeda S, et al. Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 1988;76:217-21
3. Wakabayashi K, Takahashi H, Takeda S, et al. Lewy bodies in the enteric nervous system in Parkinson's disease. Arch Histol Cytol 1989;52 Suppl: 191-4
4. Wakabayashi K, Takahashi H, Ohama E, et al. Parkinson's disease: An immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 1990;79:581-3
5. Qualman SJ, Haupt HM, Yang P, et al. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 1984;87:848-56
6. Kupsky WJ, Grimes MM, Sweeting J, et al. Parkinson's disease and megacolon: Concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 1987;37:1253-5
7. Braak H, de Vos RA, Bohl J, et al. Gastric a-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006;396:67-72
8. Braak H, Rüb U, Gai WP, et al. Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003;110:517-36
9. Hawkes CH, Del Tredici K, Braak H. Parkinson's disease: A dual-hit hypothesis. Neuropathol Appl Neurobiol 2007;33:599-614
10. Lebouvier T, Tasselli M, Paillusson S, et al. Biopsable neural tissues: Toward new biomarkers for Parkinson's disease?. Front Psychiatry 2010; 1:128
11. Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, et al. Pathological asynuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol 2016;79:940-9
12. Djaldetti R, Lev N, Melamed E. Lesions outside the CNS in Parkinson's disease. Mov Disord 2009;24:793-800
13. Pouclet H, Lebouvier T, Coron E, et al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol Dis 2012;45:305-9
14. Aldecoa I, Navarro-Otano J, Stefanova N, et al. asynuclein immunoreactivity patterns in the enteric nervous system. Neurosci Lett 2015;602:145-9
15. Shannon KM, Keshavarzian A, Dodiya HB, et al. Is a-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases. Mov Disord 2012;27:716-9
16. Shannon KM, Keshavarzian A, Mutlu E, et al. asynuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord 2012;27: 709-15
17. Lebouvier T, Neunlist M, Bruley d. V, et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One 2010;5:e12728
18. Lebouvier T, Coron E, Chaumette T, et al. Routine colonic biopsies as a new tool to study the enteric nervous system in living patients. Neurogastroenterol Motil 2010;22:e11-4
19. Lebouvier T, Chaumette T, Damier P, et al. Pathological lesions in colonic biopsies during Parkinson's disease. Gut 2008;57:1741-3
20. Pouclet H, Lebouvier T, Coron E, et al. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson's disease. Neurogastroenterol Motil 2012;45:305-9
21. Pouclet H, Lebouvier T, Coron E, et al. Analysis of colonic a-synuclein pathology in multiple system atrophy. Parkinsonism Relat Disord 2012; 18:893-5
22. Hilton D, Stephens M, Kirk L, et al. Accumulation of a-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol 2014;127:235-41
23. Gold A, Turkalp ZT, Munoz DG. Enteric a-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease. Mov Disord 2013;28:237-40
24. Gelpi E, Navarro-Otano J, Tolosa E, et al. Multiple organ involvement by a-synuclein pathology in Lewy body disorders. Mov Disord 2014;29: 1010-8
25. Masuda H, Asahina M, Oide T, et al. Antemortem detection of colonic asynuclein pathology in a patient with pure autonomic failure. J Neurol 2014;261:2451-2
26. Visanji NP, Marras C, Kern DS, et al. Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 2015;84: 609-16
27. Visanji NP, Marras C, Hazrati LN, et al. Alimentary, my dear Watson? The challenges of enteric a-synuclein as a Parkinson's disease biomarker. Mov Disord 2014;29:444-50
28. Annerino DM, Arshad S, Taylor GM, et al. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 2012;124:665-80
29. Schneider SA, Boettner M, Alexoudi A, et al. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature. Eur J Neurol 2016;23:247-61
30. Chung SJ, Kim J, Lee HJ, et al. a-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker. Mov Disord 2016;31:241-9
31. Abdi F, Quinn JF, Jankovic J, et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis 2006;9:293-348
32. Woulfe JM, Gray MT, Munoz G. Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease. Neurology 2015;85:834
33. Unger MM, Sakakibara R. Does REM sleep behavior disorder have the guts to be Parkinson disease?. Neurology 2015;85:1732-3
34. Sprenger FS, Stefanova N, Gelpi E, et al. Enteric nervous system a-synuclein immunoreactivity in idiopathic REM sleep behavior disorder. Neurology 2015;85:1761-8
35. Xuan Q, Zhang YX, Liu DG, et al. Post-translational modifications of asynuclein contribute to neurodegeneration in the colon of elderly individuals. Mol Med Rep 2016;13:5077-83
36. Malek N, Swallow D, Grosset KA, et al. a-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - A systematic review. Acta Neurol Scand 2014;130:59-72
37. Gray MT, Munoz DG, Gray DA, et al. a-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord 2014;29:991-8
38. Haga R, Sugimoto K, Nishijima H, et al. Clinical utility of skin biopsy in differentiating between Parkinson's disease and multiple system atrophy. Parkinsons Dis 2015;2015:167038
39. Donadio V, Incensi A, Piccinini C, et al. Skin nerve misfolded a-synuclein in pure autonomic failure and Parkinson disease. Ann Neurol 2016; 79:306-16
40. Donadio V, Incensi A, Leta V, et al. Skin nerve a-synuclein deposits: A biomarker for idiopathic Parkinson disease. Neurology 2014;82:1362-9
41. Donadio V, Liguori R, Incensi A, et al. Skin biopsy and microneurography disclose selective noradrenergic dysfunction due to dopamine-betahydroxylase deficiency. Auton Neurosci 2016;197:56-9
42. Doppler K, Ebert S, Uceyler N, et al. Cutaneous neuropathy in Parkinson's disease: A window into brain pathology. Acta Neuropathol 2014; 128:99-109
43. Michell AW, Luheshi LM, Barker RA. Skin and platelet a-synuclein as peripheral biomarkers of Parkinson's disease. Neurosci Lett 2005;381: 294-8
44. Shishido T, Ikemura M, Obi T, et al. a-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure. Neurology 2010;74:608-10
45. Ikemura M, Saito Y, Sengoku R, et al. Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 2008;67:945-53
46. Navarro-Otano J, Casanova-Molla J, Morales M, et al. Cutaneous autonomic denervation in Parkinson's disease. J Neural Transm 2015;122: 1149-55
47. Zange L, Noack C, Hahn K, et al. Phosphorylated a-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy. Brain 2015;138:2310-21
48. Sanchez-Ferro A, Rabano A, Catalan MJ, et al. In vivo gastric detection of a-synuclein inclusions in Parkinson's disease. Mov Disord 2015;30: 517-24
49. Ito S, Takao M, Hatsuta H, et al. a-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease. Int J Clin Exp Pathol 2014;7:1714-23
50. Beach TG, Adler CH, Sue LI, et al. Multi-organ distribution of phosphorylated a-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010;119:689-702
51. Beach TG, Adler CH, Serrano G, et al. Prevalence of submandibular gland synucleinopathy in Parkinson's disease, dementia with Lewy bodies and other Lewy body disorders. J Parkinsons Dis 2016;6:153-63
52. Mu L, Sobotka S, Chen J, et al. Altered pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol 2012;71:520-30
53. Mu L, Sobotka S, Chen J, et al. Parkinson disease affects peripheral sensory nerves in the pharynx. J Neuropathol Exp Neurol 2013;72:614-23
54. Mu L, Sobotka S, Chen J, et al. a-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol 2013;72:119-29
55. Mu L, Chen J, Sobotka S, et al. a-synuclein pathology in sensory nerve terminals of the upper aerodigestive tract of parkinson's disease patients. Dysphagia 2015;30:404-17
56. Del Tredici K, Hawkes CH, Ghebremedhin E, et al. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol 2010;119:703-13
57. Beach TG, Adler CH, Dugger BN, et al. Submandibular gland biopsy for the diagnosis of Parkinson disease. J Neuropathol Exp Neurol 2013;72:130-6
58. Adler CH, Dugger BN, Hinni ML, et al. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology 2014;82:858-64
59. Adler CH, Dugger BN, Hentz JG, et al. Peripheral synucleinopathy in early Parkinson's disease: Submandibular gland needle biopsy findings. Mov Disord 2016;31:250-6
60. Cersosimo MG, Perandones C, Micheli FE, et al. a-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients. Mov Disord 2011;26:188-90
61. Folgoas E, Lebouvier T, Leclair-Visonneau L, et al. Diagnostic value of minor salivary glands biopsy for the detection of Lewy pathology. Neurosci Lett 2013;551:62-4
62. Adler CH, Beach TG, Hentz JG, et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study. Neurology 2014;83:406-12
63. Beach TG, Tago H, Nagai T, et al. Perfusion-fixation of the human brain for immunohistochemistry: Comparison with immersion-fixation. J Neurosci Methods 1987;19:183-92
64. Comanescu M, Arsene D, Ardeleanu C, et al. The mandate for a proper preservation in histopathological tissues. Rom J Morphol Embryol 2012; 53:233-42
65. Arnold MM, Srivastava S, Fredenburgh J, et al. Effects of fixation and tissue processing on immunohistochemical demonstration of specific antigens. Biotech Histochem 1996;71:224-30
66. Leong AS, Gilham PN. The effects of progressive formaldehyde fixation on the preservation of tissue antigens. Pathology 1989;21:266-8
67. Klosen P, Maessen X, Bosch de Aguilar VD. PEG embedding for immunocytochemistry: Application to the analysis of immunoreactivity loss during histological processing. J Histochem Cytochem 1993;41:455-63
68. Beach TG, White CL, Hamilton RL, et al. Evaluation of a-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol 2008;116:277-88
69. Grizzle WE. Special symposium: Fixation and tissue processing models. Biotech Histochem 2009;84:185-93
70. Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, et al. Do asynuclein aggregates in autonomic plexuses predate Lewy body disorders?: A cohort study. Neurology 2007;68:2012-8
71. Bottner M, Zorenkov D, Hellwig I, et al. Expression pattern and localization of a-synuclein in the human enteric nervous system. Neurobiol Dis 2012;48:474-80
72. Schulz-Schaeffer WJ, Fatzer R, Vandevelde M, et al. Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch Virol Suppl 2000;173-80
73. Wemheuer WM, Wrede A, Gawinecka J, et al. Filtration of protein aggregates increases the accuracy for diagnosing prion diseases in brain biopsies. J Neuropathol Exp Neurol 2013;72:758-67
74. Preterre C, Corbillé AG, Balloy G, et al. Optimizing Western blots for the detection of endogenous a-synuclein in the enteric nervous system. J Parkinsons Dis 2015;5:765-72
75. Wang N, Gibbons CH, Lafo J, et al. a-synuclein in cutaneous autonomic nerves. Neurology 2013;81:1604-10
76. Gibbons CH, Garcia J, Wang N, et al. The diagnostic discrimination of cutaneous a-synuclein deposition in Parkinson disease. Neurology 2016; 87:505-12
77. Giannoccaro MP, Donadio V, Incensi A, et al. Skin biopsy and I-123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: A comparative study. Mov Disord 2015;30:986-9
78. Miki Y, Tomiyama M, Ueno T, et al. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease. Neurosci Lett 2010;469:357-9
79. Vilas D, Iranzo A, Tolosa E, et al. Assessment of a-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: A case-control study. Lancet Neurol 2016;15: 708-18
80. Corbille AG, Letournel F, Kordower JH, et al. Evaluation of a-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies. Acta Neuropathol Commun 2016;4:35
81. Beach TG, Corbille A-G, Letournel F, et al. Multicenter assessment of immuno-histochemical methods for pathological a-synuclein in sigmoid colon of autopsied Parkinson's disease and control subjects. J Parkinsons Dis in press 2016; 6:761-70.
82. Beach TG, Adler CH, Sue LI, et al. Arizona study of aging and neurodegenerative disorders and brain and body donation program. Neuropathology 2015;35:354-89
83. Wang N, Gibbons CH, Freeman R. Novel immunohistochemical techniques using discrete signal amplification systems for human cutaneous peripheral nerve fiber imaging. J Histochem Cytochem 2011;59:382-90
84. Anderson JP, Walker DE, Goldstein JM, et al. Phosphorylation of Ser-129 is the dominant pathological modification of a-synuclein in familial and sporadic Lewy body disease. J Biol Chem 2006;281:29739-52
85. Games D, Valera E, Spencer B, et al. Reducing C-terminal-truncated asynuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models. J Neurosci 2014;34:9441-54
86. Games D, Seubert P, Rockenstein E, et al. Axonopathy in an a-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated a-synuclein. Am J Pathol 2013;182: 940-53
87. Orimo S, Uchihara T, Nakamura A, et al. Axonal a-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008;131:642-50
88. Takahashi M, Ikemura M, Oka T, et al. Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease. J Neurol Neurosurg Psychiatry 2015; 86: 939-44
89. Stoessl AJ, Halliday GM. DAT-SPECT diagnoses dopamine depletion, but not PD. Mov Disord 2014;29:1705-6
90. Orimo S, Yogo M, Nakamura T, et al. (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in a-synucleinopathies. Ageing Res Rev 2016; 30:122-33
91. Odagiri H, Baba T, Nishio Y, et al. On the utility of MIBG SPECT/CT in evaluating cardiac sympathetic dysfunction in Lewy body diseases. PLoS One 2016; 11:e0152746
92. Guidez D, Behnke S, Halmer R, et al. Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease?. J Neurol 2014; 261:45-51
93. Rocchi C, Pierantozzi M, Galati S, et al. Autonomic function tests and MIBG in Parkinson's disease: Correlation to disease duration and motor symptoms. CNS Neurosci Ther 2015; 21:727-32